Fractyl Health, Inc. Common Stock
GUTSFractyl Health, Inc. is a clinical-stage biotech company focused on developing transformative treatments for metabolic and gastrointestinal diseases. Known for its innovative approach to advancing therapies targeting conditions like type 2 diabetes and other metabolic disorders, the company emphasizes minimally invasive procedures and novel technologies to improve patient outcomes.
Company News
Fractyl Health reported positive 6-month clinical results showing patients maintained stable weight after a single Revita procedure following GLP-1 drug discontinuation, with minimal weight change and promising metabolic control.
Shares of Cal-Maine Foods, Inc. (NASDAQ: CALM) rose sharply in today’s pre-market trading after the company reported upbeat results for its fourth quarter. The company reported quarterly earnings of $3.00 per share which beat the analyst consensus estimate of $2.46 per share, according to data from Benzinga Pro. Cal-Maine Foods shares jumped 8...
BBB Foods’ stock rises in its first day of trading as IPO market churns out deals.
